Paclitaxel Devices Safe in PAD In Medicare Data Beyond 3 Years
SAFE-PAD study update doesn't support excess mortality risk
Source: medpagetoday.com
Stay updated with breaking news from Herbd Aronow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAFE-PAD study update doesn't support excess mortality risk
Atypical rates of nonculprit STEMI have been seen in the NACMI registry, and the events are more common in women than men.